PTCT logo

PTC Therapeutics (PTCT) Depreciation And Amortization

Annual D&A

$236.59 M
+$107.75 M+83.64%

31 December 2023

1-Year Change

+83.64%
PTCT annual depreciation & amortization is up +83.64% year-on-year

3-Year Change

+444.01%
PTCT annual depreciation & amortization is up +444.01% over the past 3 years

All-time High

$236.59 M
PTCT annual depreciation & amortization is currently at an all-time high

Sector Rank

92.82%
PTCT annual depreciation & amortization is higher than 92.82% of companies in Healthcare sector
Annual Total Expenses$1.29 B
PTCT annual total expenses is $1.29 billion
Annual Operating Expenses$1.22 B
PTCT annual total operating expenses is $1.22 billion
Annual Revenue$937.82 M
PTCT annual revenue is $937.82 million
Annual Net Income-$626.60 M
PTCT annual net profit is -$626.60 million

PTCT Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$6.49 M
-$532.00 K-7.58%

30 September 2024

1-Year Change

-89.55%
PTCT quarterly depreciation & amortization is down -89.55% year-on-year

3-Year Change

-61.28%
PTCT quarterly depreciation & amortization is down -61.28% over the past 3 years

All-time High

$80.70 M
PTCT quarterly depreciation & amortization is currently -91.96% below its historical high of $80.70 million

Sector Rank

79.93%
PTCT quarterly depreciation & amortization is higher than 79.93% of companies in Healthcare sector
Quarterly Total Expenses$248.75 M
PTCT quarterly total expenses is $248.75 million
Quarterly Operating Expenses$237.90 M
PTCT quarterly total operating expenses is $237.90 million
Quarterly Revenue$196.79 M
PTCT quarterly revenue is $196.79 million
Quarterly Net Income-$106.65 M
PTCT quarterly net profit is -$106.65 million

PTCT Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$149.60 M
-$55.57 M-27.08%

30 September 2024

1-Year Change

-23.18%
PTCT TTM depreciation & amortization is down -23.18% year-on-year

3-Year Change

+159.17%
PTCT TTM depreciation & amortization is up +159.17% over the past 3 years

All-time High

$249.16 M
PTCT TTM depreciation & amortization is currently -39.96% below its historical high of $249.16 million

Sector Rank

90.52%
PTCT TTM depreciation & amortization is higher than 90.52% of companies in Healthcare sector
Annual Total Expenses$1.29 B
PTCT annual total expenses is $1.29 billion
Annual Operating Expenses$1.22 B
PTCT annual total operating expenses is $1.22 billion
TTM Revenue$900.66 M
PTCT TTM revenue is $900.66 million
TTM Net Income-$453.20 M
PTCT TTM net profit is -$453.20 million

PTCT TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PTCT Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+83.6%-89.5%-23.2%
3 y3 years+444.0%-61.3%+159.2%
5 y5 years+806.9%-20.4%+404.2%

PTCT Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+444.0%-92.0%at low-40.0%+159.2%
5 y5 yearsat high+806.9%-92.0%at low-40.0%+404.2%
alltimeall timeat high>+9999.0%-92.0%+1096.7%-40.0%>+9999.0%

PTC Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$6.49 M(-7.6%)
$149.60 M(-27.1%)
June 2024
-
$7.02 M(-87.3%)
$205.17 M(-17.7%)
Mar 2024
-
$55.40 M(-31.4%)
$249.16 M(+5.3%)
Dec 2023
$236.59 M(+83.6%)
$80.70 M(+30.1%)
$236.59 M(+21.5%)
Sept 2023
-
$62.05 M(+21.7%)
$194.75 M(+16.5%)
June 2023
-
$51.01 M(+19.1%)
$167.17 M(+15.0%)
Mar 2023
-
$42.83 M(+10.2%)
$145.35 M(+12.8%)
Dec 2022
$128.84 M(+100.9%)
$38.87 M(+12.7%)
$128.84 M(+18.4%)
Sept 2022
-
$34.48 M(+18.2%)
$108.78 M(+19.5%)
June 2022
-
$29.18 M(+10.9%)
$91.06 M(+18.5%)
Mar 2022
-
$26.31 M(+39.9%)
$76.86 M(+19.8%)
Dec 2021
$64.13 M(+47.5%)
$18.81 M(+12.3%)
$64.13 M(+11.1%)
Sept 2021
-
$16.75 M(+11.8%)
$57.73 M(+9.7%)
June 2021
-
$14.99 M(+10.3%)
$52.62 M(+10.0%)
Mar 2021
-
$13.59 M(+9.6%)
$47.84 M(+10.0%)
Dec 2020
$43.49 M(+35.1%)
$12.40 M(+6.5%)
$43.49 M(+7.7%)
Sept 2020
-
$11.64 M(+14.0%)
$40.37 M(+9.5%)
June 2020
-
$10.21 M(+10.6%)
$36.87 M(+7.3%)
Mar 2020
-
$9.23 M(-0.5%)
$34.36 M(+6.8%)
Dec 2019
$32.18 M(+23.4%)
$9.28 M(+13.9%)
$32.18 M(+8.4%)
Sept 2019
-
$8.14 M(+5.7%)
$29.67 M(+3.7%)
June 2019
-
$7.70 M(+9.1%)
$28.60 M(+5.5%)
Mar 2019
-
$7.06 M(+4.3%)
$27.12 M(+4.0%)
Dec 2018
$26.09 M
$6.77 M(-4.3%)
$26.09 M(+3.3%)
Sept 2018
-
$7.07 M(+13.7%)
$25.25 M(-11.3%)
June 2018
-
$6.22 M(+3.3%)
$28.48 M(+23.3%)
DateAnnualQuarterlyTTM
Mar 2018
-
$6.02 M(+1.4%)
$23.09 M(+30.6%)
Dec 2017
$17.68 M(+437.4%)
$5.94 M(-42.3%)
$17.68 M(+40.8%)
Sept 2017
-
$10.29 M(+1131.5%)
$12.56 M(+308.5%)
June 2017
-
$836.00 K(+36.6%)
$3.07 M(+0.7%)
Mar 2017
-
$612.00 K(-24.7%)
$3.05 M(-7.2%)
Dec 2016
$3.29 M(+14.4%)
$813.00 K(0.0%)
$3.29 M(+0.5%)
Sept 2016
-
$813.00 K(-0.2%)
$3.27 M(+1.6%)
June 2016
-
$815.00 K(-4.0%)
$3.22 M(+4.2%)
Mar 2016
-
$849.00 K(+6.5%)
$3.09 M(+7.5%)
Dec 2015
$2.88 M(+28.7%)
$797.00 K(+4.9%)
$2.88 M(+9.7%)
Sept 2015
-
$760.00 K(+10.9%)
$2.62 M(+9.0%)
June 2015
-
$685.00 K(+8.0%)
$2.40 M(+5.4%)
Mar 2015
-
$634.00 K(+17.0%)
$2.28 M(+2.1%)
Dec 2014
$2.23 M(-6.7%)
$542.00 K(-0.2%)
$2.23 M(-1.9%)
Sept 2014
-
$543.00 K(-3.4%)
$2.28 M(-2.0%)
June 2014
-
$562.00 K(-4.4%)
$2.32 M(-1.5%)
Mar 2014
-
$588.00 K(+0.5%)
$2.36 M(-1.5%)
Dec 2013
$2.40 M(-11.4%)
$585.00 K(-0.7%)
$2.40 M(-2.9%)
Sept 2013
-
$589.00 K(-1.3%)
$2.47 M(-3.1%)
June 2013
-
$597.00 K(-4.5%)
$2.54 M(-3.2%)
Mar 2013
-
$625.00 K(-4.6%)
$2.63 M(-2.8%)
Dec 2012
$2.70 M(-5.8%)
$655.30 K(-1.8%)
$2.70 M(+32.0%)
Sept 2012
-
$667.40 K(-2.1%)
$2.05 M(+48.3%)
June 2012
-
$681.60 K(-2.6%)
$1.38 M(+97.4%)
Mar 2012
-
$699.60 K
$699.60 K
Dec 2011
$2.87 M
-
-

FAQ

  • What is PTC Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for PTC Therapeutics?
  • What is PTC Therapeutics annual D&A year-on-year change?
  • What is PTC Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for PTC Therapeutics?
  • What is PTC Therapeutics quarterly D&A year-on-year change?
  • What is PTC Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for PTC Therapeutics?
  • What is PTC Therapeutics TTM D&A year-on-year change?

What is PTC Therapeutics annual depreciation & amortization?

The current annual D&A of PTCT is $236.59 M

What is the all time high annual D&A for PTC Therapeutics?

PTC Therapeutics all-time high annual depreciation & amortization is $236.59 M

What is PTC Therapeutics annual D&A year-on-year change?

Over the past year, PTCT annual depreciation & amortization has changed by +$107.75 M (+83.64%)

What is PTC Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of PTCT is $6.49 M

What is the all time high quarterly D&A for PTC Therapeutics?

PTC Therapeutics all-time high quarterly depreciation & amortization is $80.70 M

What is PTC Therapeutics quarterly D&A year-on-year change?

Over the past year, PTCT quarterly depreciation & amortization has changed by -$55.57 M (-89.55%)

What is PTC Therapeutics TTM depreciation & amortization?

The current TTM D&A of PTCT is $149.60 M

What is the all time high TTM D&A for PTC Therapeutics?

PTC Therapeutics all-time high TTM depreciation & amortization is $249.16 M

What is PTC Therapeutics TTM D&A year-on-year change?

Over the past year, PTCT TTM depreciation & amortization has changed by -$45.15 M (-23.18%)